| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Thomas Jefferson University, Department of Microbiology and Immunology, Kimmel Cancer Institute, Philadelphia, Pennsylvania 19107 [M. J. F., A. A. F., L. D. S., C. B., B. C.], and The Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, Toronto, M4X 1K9 Canada [N. N. I.]
A novel type II integral membrane protein has been identified in the course of screening for genes overexpressed in a mouse model of chronic myelogenous leukemia blast crisis. This new protein, designated NKCL, consists of a 210-amino acid polypeptide with a short, NH2-terminal cytoplasmic tail of 17 amino acids preceding a transmembrane domain and a COOH-terminal extracellular region. The COOH-terminal 132 amino acids bear typical features of the C-type animal lectin carbohydrate-recognition domain. The Nkcl gene is unique in that it maps just proximal to the region of the genome that encodes group V members of the C-type animal lectin family near the natural killer gene complex on mouse chromosome 6, but its protein product also has features of several group II C-type animal lectins. Most notably, it has a complete Ca2+-binding site 2, which forms part of the sugar-binding site in other members of the family, and binds mannose in a Ca2+-dependent manner. Moreover, its expression is not restricted to natural killer cells, as reported for the majority of group V lectins. Nkcl is expressed in pluripotent myeloid precursors, precursor and mature macrophages, and neutrophils.
This article has been cited by other articles:
![]() |
S T. Hollmig, K. Ariizumi, and P. D Cruz Jr Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2 Glycobiology, June 1, 2009; 19(6): 568 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lopes, M. Dewannieux, U. Gileadi, R. Bailey, Y. Ikeda, C. Whittaker, M. P. Collin, V. Cerundolo, M. Tomihari, K. Ariizumi, et al. Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8+ and CD4+ T-Cell Responses J. Virol., January 1, 2008; 82(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. McGreal, M. Rosas, G. D. Brown, S. Zamze, S. Y.C. Wong, S. Gordon, L. Martinez-Pomares, and P. R. Taylor The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose Glycobiology, May 1, 2006; 16(5): 422 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, L. Tang, G. Zhang, H. Wei, Y. Cui, L. Guo, Z. Gou, X. Chen, D. Jiang, Y. Zhu, et al. Characterization of a Novel C-type Lectin-like Gene, LSECtin: DEMONSTRATION OF CARBOHYDRATE BINDING AND EXPRESSION IN SINUSOIDAL ENDOTHELIAL CELLS OF LIVER AND LYMPH NODE J. Biol. Chem., April 30, 2004; 279(18): 18748 - 18758. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. kanazawa, K. Tashiro, K. Inaba, and Y. Miyachi Dendritic Cell Immunoactivating Receptor, a Novel C-type Lectin Immunoreceptor, Acts as an Activating Receptor through Association with Fc Receptor {gamma} Chain J. Biol. Chem., August 29, 2003; 278(35): 32645 - 32652. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Taylor, G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, and S. Y. C. Wong The {beta}-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages J. Immunol., October 1, 2002; 169(7): 3876 - 3882. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |